Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma

By afschroeder • April 7, 2026

Yu R, Gardner L, Salavati A, Bahri S. Prevention and Management of Peptide Receptor Radionuclide Therapy-Induced Hypertensive Crisis in a Patient With Metastatic Pheochromocytoma. AACE Endocrinol Diabetes. 2025 Nov 13;13(2):303-307. doi: 10.1016/j.aed.2025.11.001. PMID: 41938296; PMCID: PMC13043445.

Tags: Endocrinology, hypertensive crisis, lutetium-177 DOTATATE, metastatic pheochromocytoma, metyrosine, peptide receptor radionuclide therapy, Publications

Drp1 regulates mitochondrial health and controls skeletal muscle mass through the Erk1/2-Nur77 pathway

Ma AM, Tran PH, Yang NL, Ngo J, Iwasaki H, Ren W, Livit S, Stiles L, Wang S, Ho T, Yim EY, Morrow N, Johnson[...]

Choice of cardioplegia influences metabolomics of human cardiac tissue

Tanosaki S, Zhang Y, Bedi K, Margulies K, Cox JE, Arany Z, Abel ED. Choice of cardioplegia influences metabolomics of human cardiac tissue. Proc Natl[...]

Editorial: Mechanisms and novel therapeutic targets and approaches for mitochondrial dysfunction in neurological and cardiovascular diseases

Li Q, Zhang Q. Editorial: Mechanisms and novel therapeutic targets and approaches for mitochondrial dysfunction in neurological and cardiovascular diseases. Front Physiol. 2026 Apr 21;17:1840059.[...]